The role of patent analysis in target selection

Expert Opin Ther Pat. 2025 Jan 8:1-3. doi: 10.1080/13543776.2024.2447070. Online ahead of print.

Authors

Daniel H O Donovan¹, Weiping Wang², Jim Sheppeck², Gerjan de Bruin³

Affiliations

¹ Oncology R&D, AstraZeneca, Cambridge, UK.
² Oncology R&D, AstraZeneca, Waltham, MA, USA.
³ R&D, Acerta Pharma B.V., Oss, Netherlands.

PMID: 39764572
DOI: 10.1080/13543776.2024.2447070

No abstract available

Keywords: Target selection; oncology; patent analysis; patents; target validation.

Publication types

Editorial